EUVIMEDEUVIMED entdecken
Vergleichsstudie

A Comparative Study of the Global Burden of Prostate Cancer (1990–2021): Emphasis on the Disparities Between the United States and China

Junxiong Li iD, Yupeng Wu, Jian Hou iD, Haolin Liu, Yumin Wang, Feng Zhang, Peng Gu, Xiaodong Liu iD

The Prostate · 2026-03 · 86 (4) · 451-463

DOI: 10.1002/pros.70104 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Prostate, online erschienen am 02.12.2025. Verfasst von Junxiong Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: This study was supported by the Guangdong Medical Science and Technology Research Fund (Grant No. B2025832)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate Cancer (PCa) is the second most common malignancy among men worldwide, with significant heterogeneity in disease burden across countries. The United States (US) and China, representing high socio‐demographic index (SDI) countries and rapidly developing economies respectively, have distinct healthcare systems that lead to contrasting trends in PCa epidemiology. A systematic comparison of the PCa burden between the two nations from 1990 to 2021, based on the latest Global Burden of Disease (GBD) database 2021, remains limited.

Methods

Data on age‐standardized incidence rate (ASIR), prevalence rate (ASPR), mortality rate (ASMR), and disability‐adjusted life years (ASDR) of PCa were extracted from the GBD 2021 database. Joinpoint regression and estimated annual percent change (EAPC) analyses were performed to evaluate time trends. Das Gupta's decomposition method was used to quantify the relative contributions of population growth, aging and epidemiological changes on the PCa burden. Comparative analyses focused on age‐specific differences between the US and China.

Results

From 1990 to 2021, Global ASIR increased from 13.69 (12.96–14.19) to 15.37 (14.13–16.25) per 100,000; the US ASMR fell from 10.85 to 6.91 (EAPC − 1.83) while China's ASIR rose from 2.04 to 4.22 (EAPC + 2.20). The aging population accounts for 74.49% of new cases and 214.72% of cancer deaths in the US, compared to 46.62% of new cases and 79.02% of deaths in China. In the US, age‐specific incidence rates offset 32.44% of new cases, while in China, 31,610 new cases—representing 42.23%—were attributed to age‐specific rates. The divergent magnitude, age distribution, and trajectory of PCa burden between the two countries underscore the urgent need for country‐specific strategies.

Conclusion

The PCa burden in the US and China has evolved in markedly different directions over the past three decades, reflecting profound impact in screening strategies and population aging. High SDI countries should refine risk‐based screening protocols and management strategies. Meanwhile, China and other low and middle SDI countries must expand early, targeted screening for high‐risk populations and strengthen primary healthcare to mitigate the growing burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsHumansMaleChinaUnited StatesGlobal Burden of DiseaseAgedMiddle AgedIncidencePrevalenceAdultDisability-Adjusted Life YearsCost of Illness

Stichwörter der Autor:innen

PSA screeningdifferences between the United States and Chinaglobal burden of diseasepopulation agingprostate cancer

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Urology, Heyou Hospital, Guangdong, China.
  • Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Junxiong Li, Jian Hou, Xiaodong Liu

Förderung

  • This study was supported by the Guangdong Medical Science and Technology Research Fund (Grant No. B2025832).

Zitieren

APA

Li, J., Wu, Y., Hou, J., Liu, H., Wang, Y., Zhang, F., Gu, P., & Liu, X. (2026). A Comparative Study of the Global Burden of Prostate Cancer (1990–2021): Emphasis on the Disparities Between the United States and China. The Prostate, 86(4), 451-463. https://doi.org/10.1002/pros.70104

Vancouver

Li J, Wu Y, Hou J, Liu H, Wang Y, Zhang F, et al. A Comparative Study of the Global Burden of Prostate Cancer (1990–2021): Emphasis on the Disparities Between the United States and China. The Prostate. 2026;86(4):451-463. doi:10.1002/pros.70104

BibTeX
@article{Li2026,
  author = {Li, Junxiong and Wu, Yupeng and Hou, Jian and Liu, Haolin and Wang, Yumin and Zhang, Feng and Gu, Peng and Liu, Xiaodong},
  title = {A Comparative Study of the Global Burden of Prostate Cancer (1990–2021): Emphasis on the Disparities Between the United States and China},
  journal = {The Prostate},
  year = {2026},
  volume = {86},
  number = {4},
  pages = {451--463},
  doi = {10.1002/pros.70104}
}
Kostenlos starten →